CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3023% above fair value
$79.81−1.36 (-1.68%)
Close on Nov 12, 2026Market cap $4.19BP/E 33.4Yield –
CareDx gross margin
Gross margin is gross profit as a percentage of revenue.
CareDx's gross margin for the twelve months ending Jun 30, 2020 was 65.5%. For fiscal 2019 it was 64.2%, against 56.9% the year before. The highest annual figure on record is 100.0% in fiscal 2014.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | 64.2% | +7.3 |
| FY2018 | Dec 31, 2018 | 56.9% | +1.1 |
| FY2017 | Dec 31, 2017 | 55.8% | −19.0 |
| FY2016 | Dec 31, 2016 | 74.8% | −25.2 |
| FY2015 | Dec 31, 2015 | 100.0% | +0.0 |
| FY2014 | Dec 31, 2014 | 100.0% | +41.1 |
| FY2013 | Dec 31, 2013 | 58.9% | −2.3 |
| FY2012 | Dec 31, 2012 | 61.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | 64.1% | +0.7 |
| Q1 FY2020 | Mar 31, 2020 | 67.7% | +5.2 |
| Q4 FY2019 | Dec 31, 2019 | 64.5% | +9.2 |
| Q3 FY2019 | Sep 30, 2019 | 66.0% | +8.0 |
| Q2 FY2019 | Jun 30, 2019 | 63.4% | +3.8 |
| Q1 FY2019 | Mar 31, 2019 | 62.5% | −21.3 |
| Q4 FY2018 | Dec 31, 2018 | 55.3% | +73.8 |
| Q3 FY2018 | Sep 30, 2018 | 58.0% | −25.1 |
| Q2 FY2018 | Jun 30, 2018 | 59.6% | −22.4 |
| Q1 FY2018 | Mar 31, 2018 | 83.8% | +3.9 |
| Q4 FY2017 | Dec 31, 2017 | -18.5% | −83.2 |
| Q3 FY2017 | Sep 30, 2017 | 83.2% | – |
| Q2 FY2017 | Jun 30, 2017 | 81.9% | – |
| Q1 FY2017 | Mar 31, 2017 | 79.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 64.7% | – |
See a number that looks wrong?